Of note, nCHI3L1 Ab treatment promoted higher CD8+ T cells to FOXP3+ Tregs (CD8+/Treg) ratio infiltrating into the inner tumor regions as compared to the IgG group (Figure 8D-F). The gene discussed is CD8A; the disease is neoplasm.